pentoxifylline has been researched along with Glial Cell Tumors in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sinn, B | 1 |
| Tallen, G | 1 |
| Schroeder, G | 1 |
| Grassl, B | 1 |
| Schulze, J | 1 |
| Budach, V | 1 |
| Tinhofer, I | 1 |
| Eley, KW | 1 |
| Benedict, SH | 1 |
| Chung, TD | 1 |
| Kavanagh, BD | 1 |
| Broaddus, WC | 1 |
| Schmidt-Ullrich, RK | 1 |
| Lin, PS | 1 |
2 other studies available for pentoxifylline and Glial Cell Tumors
| Article | Year |
|---|---|
Caffeine confers radiosensitization of PTEN-deficient malignant glioma cells by enhancing ionizing radiation-induced G1 arrest and negatively regulating Akt phosphorylation.
Topics: Animals; Brain Neoplasms; Caffeine; Cell Line, Tumor; Cell Survival; DNA Damage; G1 Phase; Gene Expr | 2010 |
The effects of pentoxifylline on the survival of human glioma cells with continuous and intermittent stereotactic radiosurgery irradiation.
Topics: Cell Survival; DNA Repair; Flow Cytometry; G2 Phase; Glioma; Humans; Pentoxifylline; Radiation Dosag | 2002 |